OnKure Therapeutics, Inc. (OKUR)
2.37
-0.16
(-6.14%)
USD |
NASDAQ |
Nov 06, 10:13
OnKure Therapeutics Total Liabilities (Quarterly) : 9.34M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 9.34M |
| June 30, 2026 | 7.245M |
| March 31, 2026 | 14.34M |
| December 31, 2025 | 5.933M |
| September 30, 2025 | 6.407M |
| June 30, 2025 | 7.904M |
| March 31, 2025 | 9.234M |
| December 31, 2024 | 11.08M |
| September 30, 2024 | 3.627M |
| June 30, 2024 | 1.848M |
| March 31, 2024 | 3.397M |
| December 31, 2023 | 7.751M |
| Date | Value |
|---|---|
| September 30, 2023 | 15.44M |
| June 30, 2023 | 15.51M |
| March 31, 2023 | 11.78M |
| December 31, 2022 | 8.212M |
| September 30, 2022 | 10.46M |
| June 30, 2022 | 9.451M |
| March 31, 2022 | 9.094M |
| December 31, 2021 | 6.813M |
| September 30, 2021 | 6.735M |
| June 30, 2021 | 3.753M |
| March 31, 2021 | 144.04M |
| December 31, 2020 | 97.34M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 245.35M |
| Tonix Pharmaceuticals Holding Corp. | 31.81M |
| Karyopharm Therapeutics, Inc. | 441.48M |
| Minerva Neurosciences, Inc. | 308.39M |
| Corbus Pharmaceuticals Holdings, Inc. | 24.75M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 167.08M |
| Shareholders Equity (Quarterly) | 157.74M |
| Debt to Equity Ratio | 0.005 |
| Current Ratio | 18.84 |
| Net Debt Paydown Yield | 0.01% |